Interesting Phase 1 results for a Lassa fever and rabies combo vaccine. LASSARAB was safe and well-tolerated in 54 healthy adults, showing strong immune responses to both. A good step forward.
Researchers have reported encouraging results from the first human clinical trial (Phase 1) of LASSARAB, an experimental vaccine designed to protect against both Lassa fever and rabies in a single for
